S. 2476 · 115th Congress
Expanding Access to Low Cost Generic Drugs Act
- Stage
- In committee
- Sponsor
- Tina Smith
- Introduced
- 2018-02-28
- Latest action
- 2018-02-28 · Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Summary
Expanding Access to Low Cost Generic Drugs Act
This bill amends the Federal Food, Drug, and Cosmetic Act to disqualify from receiving market exclusivity a generic drug manufacturer who enters into an agreement with the patent holder for a brand name drug to delay getting the generic drug approved or to delay marketing it.